At Endeavor Pharma Solutions, we transform groundbreaking therapies into market success stories. Our unparalleled expertise cuts through the complexity of pharmaceutical market access, creating clear pathways for innovative treatments.
Endeavor Pharma Solutions was founded by Laura Viaches, a Harvard MBA and recipient of the prestigious 2023 Baldrige Foundation Award for Leadership Excellence in the Business Sector. Drawing from more than two decades of senior leadership experience within Eli Lilly and Company’s highly regarded Market Access division, Laura brings unparalleled expertise in pharmaceutical commercialization strategy. During her tenure at Lilly, she led high-performing teams across Alzheimer’s Disease Market Access, Patient Services, and Health Systems Account Management, driving breakthrough results in market access strategy, patient support programs, and payer engagement.
We exist to bridge the critical gap between pharmaceutical innovation and market success. Through strategic consulting and hands-on experience, we architect custom solutions that help breakthrough therapies reach the patients who need them most. Our deep understanding of the U.S. healthcare landscape, combined with our practical experience in market access strategy, enables us to deliver actionable insights that drive measurable results.
Our team brings decades of experience from leadership roles in big pharma, having successfully navigated the complexities of pricing, reimbursement, and patient access across multiple therapeutic areas. We understand the intricate dynamics between payers, providers, and patients because we've been at the forefront of developing and implementing market access strategies that work.
We recognize that every client's challenge is unique. Whether you're a biotech startup preparing for your first launch, an investment firm evaluating healthcare assets, or a service provider looking to strengthen pharmaceutical partnerships, we tailor our approach to your specific needs and objectives.
Our founder's selection as a 2023 recipient of the Baldrige Foundation Award for Leadership Excellence in the Business Sector places her among an elite group of national leaders recognized for their exceptional contributions to organizational excellence. This prestigious award, presented by the Foundation for the Malcolm Baldrige National Quality Award, Inc., acknowledges leaders who exemplify the highest standards of organizational performance excellence, innovation, and sustainable success. The award represents the Foundation's recognition of leaders who make transformative impacts across various sectors of the American economy, from healthcare and government to education and cybersecurity. Laura's recognition alongside distinguished leaders from organizations such as Intermountain Healthcare, Tata International, and other industry pioneers reflects her significant contributions to advancing performance excellence principles in pharmaceutical market access and patient support services. This achievement builds on her track record of leading organizations to multiple state-level Baldrige awards and fostering cultures of continuous improvement and operational excellence.
Our recommendations aren't just theoretical – they're grounded in practical experience and proven success. We combine strategic thinking with operational know-how to deliver solutions that are both innovative and implementable.
We partner with forward-thinking organizations across the healthcare ecosystem:
Through these partnerships, we’ve helped clients achieve remarkable outcomes, from securing optimal market access for novel therapies to designing patient support programs that set new industry standards.
Biotechnology companies seeking to optimize their commercial strategy and enhance asset valuation through compelling market narratives
Venture capital and private equity firms evaluating pharmaceutical assets
Specialty pharmacies, infusion centers, and other healthcare service providers seeking to demonstrate and maximize their value to pharmaceutical partners
Pharmaceutical companies navigating complex market access challenges
We are committed to accelerating access to innovative therapies by creating clear pathways to market success. Our work goes beyond consulting – we are passionate about transforming the healthcare landscape by ensuring that breakthrough treatments reach the patients who need them, while delivering sustainable value to our clients and the healthcare system as a whole.
At Endeavor Pharma Solutions, we’re not just advisors – we’re your partners in navigating the complex journey from innovation to access.
